📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial. (2022)

First Author: Stone W

Attributed to: Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(21)00192-0

PubMed Identifier: 35028628

Publication URI: http://europepmc.org/abstract/MED/35028628

Type: Journal Article/Review

Volume: 3

Parent Publication: The Lancet. Microbe

Issue: 1

ISSN: 2666-5247